Movatterモバイル変換

[0]ホーム
URL:

GB9926437D0 - Pharmaceutical - Google Patents

Pharmaceutical

Info

Publication number
GB9926437D0
GB9926437D0GB9926437AGB9926437AGB9926437D0GB 9926437 D0GB9926437 D0GB 9926437D0GB 9926437 AGB9926437 AGB 9926437AGB 9926437 AGB9926437 AGB 9926437AGB 9926437 D0GB9926437 D0GB 9926437D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB9926437A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd Great Britain
Original Assignee
Pfizer Ltd Great Britain
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd Great BritainfiledCriticalPfizer Ltd Great Britain
Priority to GB9926437ApriorityCriticalpatent/GB9926437D0/en
Publication of GB9926437D0publicationCriticalpatent/GB9926437D0/en
Priority to IL13945400Aprioritypatent/IL139454A0/en
Priority to IL13945600Aprioritypatent/IL139456A0/en
Priority to IL13945700Aprioritypatent/IL139457A0/en
Priority to IL13945500Aprioritypatent/IL139455A0/en
Priority to SK1670-2000Aprioritypatent/SK16702000A3/en
Priority to EP20000309719prioritypatent/EP1097707A1/en
Priority to EP00309722Aprioritypatent/EP1097719B1/en
Priority to PT00309722Tprioritypatent/PT1097719E/en
Priority to DE60016877Tprioritypatent/DE60016877T2/en
Priority to EP20000309720prioritypatent/EP1097718A1/en
Priority to SK1671-2000Aprioritypatent/SK16712000A3/en
Priority to DK00309722Tprioritypatent/DK1097719T3/en
Priority to EP20040020972prioritypatent/EP1481667A1/en
Priority to AT00309722Tprioritypatent/ATE285249T1/en
Priority to ES00309722Tprioritypatent/ES2233297T3/en
Priority to SK1672-2000Aprioritypatent/SK16722000A3/en
Priority to EP00309718Aprioritypatent/EP1097706A1/en
Priority to ZA200006376Aprioritypatent/ZA200006376B/en
Priority to MYPI20005205Aprioritypatent/MY140534A/en
Priority to ZA200006375Aprioritypatent/ZA200006375B/en
Priority to AU71409/00Aprioritypatent/AU7140900A/en
Priority to AU71408/00Aprioritypatent/AU781403B2/en
Priority to ZA200006374Aprioritypatent/ZA200006374B/en
Priority to AU71407/00Aprioritypatent/AU781400B2/en
Priority to MYPI20005202Aprioritypatent/MY141651A/en
Priority to CZ20004106Aprioritypatent/CZ20004106A3/en
Priority to ZA200006378Aprioritypatent/ZA200006378B/en
Priority to AU71411/00Aprioritypatent/AU781186B2/en
Priority to CZ20004110Aprioritypatent/CZ20004110A3/en
Priority to CZ20004107Aprioritypatent/CZ20004107A3/en
Priority to HU0004349Aprioritypatent/HUP0004349A2/en
Priority to KR1020000065740Aprioritypatent/KR20010051481A/en
Priority to CN00137665Aprioritypatent/CN1320426A/en
Priority to PE2000001185Aprioritypatent/PE20010817A1/en
Priority to NO20005618Aprioritypatent/NO20005618L/en
Priority to KR1020000065868Aprioritypatent/KR20010086267A/en
Priority to PE2000001187Aprioritypatent/PE20010926A1/en
Priority to CN00137671Aprioritypatent/CN1322526A/en
Priority to HU0004347Aprioritypatent/HUP0004347A2/en
Priority to CA002323191Aprioritypatent/CA2323191A1/en
Priority to CO00084519Aprioritypatent/CO5680108A1/en
Priority to CA002324484Aprioritypatent/CA2324484A1/en
Priority to CA002323183Aprioritypatent/CA2323183A1/en
Priority to CNA2004100859558Aprioritypatent/CN1636597A/en
Priority to NZ508007Aprioritypatent/NZ508007A/en
Priority to NO20005661Aprioritypatent/NO20005661L/en
Priority to NO20005662Aprioritypatent/NO20005662L/en
Priority to NZ508006Aprioritypatent/NZ508006A/en
Priority to PE2000001188Aprioritypatent/PE20010925A1/en
Priority to HU0004350Aprioritypatent/HUP0004350A2/en
Priority to BR0005266-3Aprioritypatent/BR0005266A/en
Priority to CN00137670Aprioritypatent/CN1328824A/en
Priority to PE2000001186Aprioritypatent/PE20010924A1/en
Priority to KR1020000065863Aprioritypatent/KR20010082545A/en
Priority to NZ508012Aprioritypatent/NZ508012A/en
Priority to HU0004348Aprioritypatent/HUP0004348A2/en
Priority to CO00084521Aprioritypatent/CO5680109A1/en
Priority to CA002323464Aprioritypatent/CA2323464A1/en
Priority to NZ508011Aprioritypatent/NZ508011A/en
Priority to CNA2004100713908Aprioritypatent/CN1575816A/en
Priority to KR1020000065761Aprioritypatent/KR20010082544A/en
Priority to EA200001043Aprioritypatent/EA006254B1/en
Priority to JP2000339957Aprioritypatent/JP2001247479A/en
Priority to BR0005299-0Aprioritypatent/BR0005299A/en
Priority to PL00343753Aprioritypatent/PL343753A1/en
Priority to JP2000339853Aprioritypatent/JP2001213802A/en
Priority to PL00343755Aprioritypatent/PL343755A1/en
Priority to EA200001044Aprioritypatent/EA006242B1/en
Priority to JP2000339905Aprioritypatent/JP2001206855A/en
Priority to EA200001042Aprioritypatent/EA200001042A3/en
Priority to PL00343754Aprioritypatent/PL343754A1/en
Priority to BR0005276-0Aprioritypatent/BR0005276A/en
Priority to US09/708,392prioritypatent/US6734186B1/en
Priority to JP2000339949Aprioritypatent/JP2001247478A/en
Priority to HK02102195.7Aprioritypatent/HK1040626A1/en
Priority to HK02102197.5Aprioritypatent/HK1040627A1/en
Priority to HK02103406.0Aprioritypatent/HK1041646A1/en
Priority to US10/686,282prioritypatent/US20050020547A1/en
Priority to US10/686,390prioritypatent/US20040254153A1/en
Priority to US10/686,349prioritypatent/US20050070499A1/en
Priority to KR1020040050971Aprioritypatent/KR20040074021A/en
Priority to KR1020040050972Aprioritypatent/KR20040074022A/en
Priority to KR1020040050973Aprioritypatent/KR20040074023A/en
Priority to JP2004267669Aprioritypatent/JP2005021167A/en
Priority to JP2004268608Aprioritypatent/JP2005013237A/en
Priority to JP2004269732Aprioritypatent/JP2005070055A/en
Priority to JP2004269807Aprioritypatent/JP2005043377A/en
Priority to AU2005202166Aprioritypatent/AU2005202166A1/en
Priority to AU2005202750Aprioritypatent/AU2005202750A1/en
Priority to JP2005233224Aprioritypatent/JP2005350482A/en
Ceasedlegal-statusCriticalCurrent

Links

GB9926437A1999-11-081999-11-08PharmaceuticalCeasedGB9926437D0 (en)

Priority Applications (91)

Application NumberPriority DateFiling DateTitle
GB9926437AGB9926437D0 (en)1999-11-081999-11-08Pharmaceutical
IL13945400AIL139454A0 (en)1999-11-082000-11-02Compounds for the treatment of female sexual dysfunction
IL13945600AIL139456A0 (en)1999-11-082000-11-02Compounds for the treatment of female sexual dysfunction
IL13945700AIL139457A0 (en)1999-11-082000-11-02Compounds for the treatment of female sexual dysfunction
IL13945500AIL139455A0 (en)1999-11-082000-11-02Compounds for the treatment of female sexual dysfunction
SK1670-2000ASK16702000A3 (en)1999-11-082000-11-03Compounds for the treatment of female sexual dysfunction
EP20000309719EP1097707A1 (en)1999-11-082000-11-03Treatment of female sexual dysfunction
EP00309722AEP1097719B1 (en)1999-11-082000-11-03NEP inhibitors for the treatment of female sexual dysfunction
PT00309722TPT1097719E (en)1999-11-082000-11-03 COMPOUNDS FOR THE TREATMENT OF FEMALE SEXUAL DYSFUNCTION
DE60016877TDE60016877T2 (en)1999-11-082000-11-03 NEP inhibitors for the treatment of female sexual disorders
EP20000309720EP1097718A1 (en)1999-11-082000-11-03NPY antagonists for the treatment of female sexual dysfunction
SK1671-2000ASK16712000A3 (en)1999-11-082000-11-03Compounds for the treatment of female sexual dysfunction
DK00309722TDK1097719T3 (en)1999-11-082000-11-03 Use of compounds for the treatment of female sexual dysfunction
EP20040020972EP1481667A1 (en)1999-11-082000-11-03NEP inhibitors for the treatment of female sexual dysfunction
AT00309722TATE285249T1 (en)1999-11-082000-11-03 NEP INHIBITORS FOR THE TREATMENT OF FEMALE SEXUAL DISORDERS
ES00309722TES2233297T3 (en)1999-11-082000-11-03 INHIBITORS OF THE NEUTRAL ENDOPEPTIDASE (NEP) FOR THE TREATMENT OF FEMALE SEXUAL DYSFUNCTION.
SK1672-2000ASK16722000A3 (en)1999-11-082000-11-03Compounds for the treatment of female sexual dysfunction
EP00309718AEP1097706A1 (en)1999-11-082000-11-03Phosphodiesterase inhibitors for the treatment of female sexual dysfunction
ZA200006376AZA200006376B (en)1999-11-082000-11-06Compounds for the treatment of female sexual dysfunction.
MYPI20005205AMY140534A (en)1999-11-082000-11-06Compounds for the treatment of female sexual dysfunction
ZA200006375AZA200006375B (en)1999-11-082000-11-06Compounds for the treatment of female sexual dysfunction.
AU71409/00AAU7140900A (en)1999-11-082000-11-06Compounds for the treatment of female sexual dysfunction
AU71408/00AAU781403B2 (en)1999-11-082000-11-06Compounds for the treatment of female sexual dysfunction
ZA200006374AZA200006374B (en)1999-11-082000-11-06Compound for the treatment of female sexual dysfunction.
AU71407/00AAU781400B2 (en)1999-11-082000-11-06Compounds for the treatment of female sexual dysfunction
MYPI20005202AMY141651A (en)1999-11-082000-11-06Nep inhibitors for the treatment of female sexual dysfunction
CZ20004106ACZ20004106A3 (en)1999-11-082000-11-06Compounds for treating sexual dysfunction in women
ZA200006378AZA200006378B (en)1999-11-082000-11-06Compounds for the treatment of female sexual dysfunction.
AU71411/00AAU781186B2 (en)1999-11-082000-11-06Compounds for the treatment of female sexual dysfunction
CZ20004110ACZ20004110A3 (en)1999-11-082000-11-06Compounds for treating sexual dysfunction in women
CZ20004107ACZ20004107A3 (en)1999-11-082000-11-06Compounds for treating sexual dysfunction in women
HU0004349AHUP0004349A2 (en)1999-11-082000-11-07Compounds for the treatment of female sexual dysfunction
KR1020000065740AKR20010051481A (en)1999-11-082000-11-07Compounds for the Treatment of Female Sexual Dysfunction
CN00137665ACN1320426A (en)1999-11-082000-11-07 Compounds for the treatment of female sexual dysfunction
PE2000001185APE20010817A1 (en)1999-11-082000-11-07 COMPOUNDS FOR THE TREATMENT OF FEMALE SEXUAL DYSFUNCTION
NO20005618ANO20005618L (en)1999-11-082000-11-07 Components for the treatment of female sexual dysfunction
KR1020000065868AKR20010086267A (en)1999-11-082000-11-07Compounds for the Treatment of Female Sexual Dysfunction
PE2000001187APE20010926A1 (en)1999-11-082000-11-07 USEFUL ENDOPEPTIDASE INHIBITING COMPOUNDS FOR THE TREATMENT OF FEMALE SEXUAL DYSFUNCTION
CN00137671ACN1322526A (en)1999-11-082000-11-07Compound for treating female sexual dysfunction
HU0004347AHUP0004347A2 (en)1999-11-082000-11-07Compounds for the treatment of female sexual dysfunction
CA002323191ACA2323191A1 (en)1999-11-082000-11-07Compounds for the treatment of female sexual dysfunction
CO00084519ACO5680108A1 (en)1999-11-082000-11-07 COMPOUNDS FOR THE TREATMENT OF FEMALE SEXUAL DYSFUNCTION
CA002324484ACA2324484A1 (en)1999-11-082000-11-07Compounds for the treatment of female sexual dysfunction
CA002323183ACA2323183A1 (en)1999-11-082000-11-07Compounds for the treatment of female sexual dysfunction
CNA2004100859558ACN1636597A (en)1999-11-082000-11-07Compounds for the treatment of female sexual dysfunction
NZ508007ANZ508007A (en)1999-11-082000-11-07Compounds for the treatment of female sexual dysfunction that potentiate cAMP activity and is an inhibitor of neuropeptide-Y (NPY)
NO20005661ANO20005661L (en)1999-11-082000-11-07 Components for the treatment of female sexual dysfunction
NO20005662ANO20005662L (en)1999-11-082000-11-07 Components for the treatment of female sexual dysfunction
NZ508006ANZ508006A (en)1999-11-082000-11-07Compounds that potentiate cAMP responses for treatment of female impotence
PE2000001188APE20010925A1 (en)1999-11-082000-11-07 NEUROPEPTIDE INHIBITING COMPOUNDS AND USEFUL FOR THE TREATMENT OF FEMALE SEXUAL DYSFUNCTION
HU0004350AHUP0004350A2 (en)1999-11-082000-11-07Compounds for the treatment of female sexual dysfunction
BR0005266-3ABR0005266A (en)1999-11-082000-11-07 Compounds for the treatment of female sexual dysfunction
CN00137670ACN1328824A (en)1999-11-082000-11-07 Compounds for the treatment of female sexual dysfunction
PE2000001186APE20010924A1 (en)1999-11-082000-11-07 USEFUL PHOSPHODIESTERASE INHIBITING COMPOUNDS FOR THE TREATMENT OF FEMALE SEXUAL DYSFUNCTION
KR1020000065863AKR20010082545A (en)1999-11-082000-11-07Compounds for the Treatment of Female Sexual Dysfunction
NZ508012ANZ508012A (en)1999-11-082000-11-07Compounds that potentiate cAMP and is an inhibitor of NEP (neutral endopeptidase) (enkaplinhalinase)
HU0004348AHUP0004348A2 (en)1999-11-082000-11-07Compounds for the treatment of female sexual dysfunction
CO00084521ACO5680109A1 (en)1999-11-082000-11-07 COMPOUNDS FOR THE TREATMENT OF FEMALE SEXUAL DYSFUNCTION
CA002323464ACA2323464A1 (en)1999-11-082000-11-07Compounds for the treatment of female sexual dysfunction
NZ508011ANZ508011A (en)1999-11-082000-11-07Compounds that inhibit phosphodiesterase activity which results in potentiation of cAMP or cGMP to promote smooth muscle vasodilation
CNA2004100713908ACN1575816A (en)1999-11-082000-11-07Compounds for the treatment of female sexual dysfunction
KR1020000065761AKR20010082544A (en)1999-11-082000-11-07Compounds for the Treatment of Female Sexual Dysfunction
EA200001043AEA006254B1 (en)1999-11-082000-11-08I:npy inhibitor for treating female sexual dysfunction
JP2000339957AJP2001247479A (en)1999-11-082000-11-08 Compounds for the treatment of female sexual dysfunction
BR0005299-0ABR0005299A (en)1999-11-082000-11-08 Compounds for the treatment of female sexual dysfunction
PL00343753APL343753A1 (en)1999-11-082000-11-08Pharmacological composition, application of an agent in production of a drug, method of therapeutically treating female patients, testing method in order to identify said agend, method of identifying said agent, diagnosing method, diagnostic composition, animal model for use in identification of said agent and method of obtaining a drug
JP2000339853AJP2001213802A (en)1999-11-082000-11-08 Compounds for the treatment of female sexual dysfunction
PL00343755APL343755A1 (en)1999-11-082000-11-08Pharmacological composition, application of an agent in production of a drug, method of therapeutically treating female patients, testing method in order to identify said agent, method of identifying said agend, diagnosing method, diagnostic composition, animal model for use in identification of said agent and method of obtaining a drug
EA200001044AEA006242B1 (en)1999-11-082000-11-08Nep inhibitors for the treatment of female sexual disfunction
JP2000339905AJP2001206855A (en)1999-11-082000-11-08 Compounds for the treatment of female sexual dysfunction
EA200001042AEA200001042A3 (en)1999-11-082000-11-08 CONNECTIONS FOR THE TREATMENT OF FEMALE SEXUAL DYSFUNCTION
PL00343754APL343754A1 (en)1999-11-082000-11-08Pharmacological composition, application of an agent in production of a drug, method of therapeutically treating female patients, testing method in order to identify said agent, method of identifying said agent, diagnosing method, diagnostic composition, animal model for use in identification of said agent and method of obtaining a drug
BR0005276-0ABR0005276A (en)1999-11-082000-11-08 Compounds for the treatment of female sexual dysfunction
US09/708,392US6734186B1 (en)1999-11-082000-11-08Compounds for the treatment of female sexual dysfunction
JP2000339949AJP2001247478A (en)1999-11-082000-11-08 Compounds for the treatment of female sexual dysfunction
HK02102195.7AHK1040626A1 (en)1999-11-082002-03-22Compounds for the treatment of female sexual dysfunction
HK02102197.5AHK1040627A1 (en)1999-11-082002-03-22Compounds for the treatment of female sexual dysfunction
HK02103406.0AHK1041646A1 (en)1999-11-082002-05-04Compounds for the treatment of female sexual dysfunction
US10/686,282US20050020547A1 (en)1999-11-082003-10-15Compounds for the treatment of female sexual dysfunction
US10/686,390US20040254153A1 (en)1999-11-082003-10-15Compounds for the treatment of female sexual dysfunction
US10/686,349US20050070499A1 (en)1999-11-082003-10-15Compounds for the treatment of female sexual dysfunction
KR1020040050971AKR20040074021A (en)1999-11-082004-07-01Compounds for the Treatment of Female Sexual Dysfunction
KR1020040050972AKR20040074022A (en)1999-11-082004-07-01Compounds for the Treatment of Female Sexual Dysfunction
KR1020040050973AKR20040074023A (en)1999-11-082004-07-01Compounds for the Treatment of Female Sexual Dysfunction
JP2004267669AJP2005021167A (en)1999-11-082004-09-15 Assay methods for identifying agents for treatment of female sexual dysfunction (FSD), methods and kits for detecting female sexual dysfunction, and non-human animal models of female sexual dysfunction
JP2004268608AJP2005013237A (en)1999-11-082004-09-15 Assay methods for identifying agents for treatment of female sexual dysfunction (FSD), methods and kits for detecting female sexual dysfunction, and non-human animal models of female sexual dysfunction
JP2004269732AJP2005070055A (en)1999-11-082004-09-16 Assay methods for identifying agents for treatment of female sexual dysfunction (FSD), methods and kits for detecting female sexual dysfunction, and non-human animal models of female sexual dysfunction
JP2004269807AJP2005043377A (en)1999-11-082004-09-16 Drugs for the treatment of female sexual dysfunction
AU2005202166AAU2005202166A1 (en)1999-11-082005-05-18Compounds for the Treatment of Female Sexual Dysfunction
AU2005202750AAU2005202750A1 (en)1999-11-082005-06-23Compounds for the treatment of female sexual dysfunction
JP2005233224AJP2005350482A (en)1999-11-082005-08-11 Compounds for the treatment of FSD

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
GB9926437AGB9926437D0 (en)1999-11-081999-11-08Pharmaceutical

Publications (1)

Publication NumberPublication Date
GB9926437D0true GB9926437D0 (en)2000-01-12

Family

ID=10864170

Family Applications (1)

Application NumberTitlePriority DateFiling Date
GB9926437ACeasedGB9926437D0 (en)1999-11-081999-11-08Pharmaceutical

Country Status (2)

CountryLink
GB (1)GB9926437D0 (en)
ZA (4)ZA200006375B (en)

Also Published As

Publication numberPublication date
ZA200006376B (en)2002-05-06
ZA200006374B (en)2002-05-06
ZA200006378B (en)2002-05-06
ZA200006375B (en)2002-05-06

Similar Documents

PublicationPublication DateTitle
PL351387A1 (en)Pharmaceutical composition
EG23858A (en)Drug combination
PL351686A1 (en)Novel pharmaceutical
HUP0203585A3 (en)Pharmaceutical combinations
IL145632A0 (en)Pharmaceutical compounds
EG23937A (en)Novel pharmaceutical
GB9930079D0 (en)Medicaments
GB9930071D0 (en)Medicaments
GB9916434D0 (en)Pharmaceutical compounds
GB9914255D0 (en)Pharmaceutical compounds
GB9909041D0 (en)Novel pharmaceutical
EG23946A (en)Novel pharmaceutical
GB9915231D0 (en)Pharmaceutical complex
GB9903784D0 (en)Pharmaceutical compounds
GB2373499B (en)Pharmaceutical compounds
GB9924990D0 (en)Medicaments
GB9930083D0 (en)Medicaments
GB9929040D0 (en)Medicaments
GB9923933D0 (en)Novel pharmaceutical
GB9904935D0 (en)Medicaments
GB9923934D0 (en)Novel pharmaceutical
GB9926434D0 (en)Pharmaceutical
GB9926437D0 (en)Pharmaceutical
GB9929039D0 (en)Medicaments
GB9912195D0 (en)Novel pharmaceutical

Legal Events

DateCodeTitleDescription
ATApplications terminated before publication under section 16(1)
[8]ページ先頭
©2009-2025 Movatter.jp